$478 Million is the total value of DAFNA Capital Management LLC's 84 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 21.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STXS | STEREOTAXIS INC | $131,881,000 | +43.5% | 13,680,554 | 0.0% | 27.58% | +26.4% | |
| FATE | FATE THERAPEUTICS INC | $27,283,000 | +5.3% | 314,360 | 0.0% | 5.71% | -7.2% | |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $19,061,000 | +26.8% | 510,756 | -13.1% | 3.99% | +11.8% |
| BPMC | BLUEPRINT MEDICINES CORP | $18,288,000 | -9.5% | 207,911 | 0.0% | 3.82% | -20.2% | |
| TBPH | Buy | THERAVANCE BIOPHARMA INC | $10,634,000 | +1166.0% | 732,345 | +1679.0% | 2.22% | +1017.6% |
| MORF | MORPHIC HOLDING INC | $10,414,000 | -9.3% | 181,467 | 0.0% | 2.18% | -20.0% | |
| TBIO | Buy | TRANSLATE BIO INC | $10,382,000 | +179.3% | 376,993 | +67.3% | 2.17% | +146.1% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $9,675,000 | -28.7% | 170,306 | -6.1% | 2.02% | -37.2% |
| BHVN | Buy | BIOHAVEN PHARMACEUTICALS HOLD | $9,135,000 | +42.8% | 94,100 | +0.5% | 1.91% | +25.8% |
| DXCM | DEXCOM INC | $9,026,000 | +18.8% | 21,138 | 0.0% | 1.89% | +4.8% | |
| AFMD | Sell | AFFIMED N V | $8,201,000 | +4.7% | 964,857 | -2.5% | 1.72% | -7.7% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $8,158,000 | +53.3% | 119,615 | +55.9% | 1.71% | +35.1% |
| NRIX | NURIX THERAPEUTICS INC | $8,127,000 | -14.7% | 306,320 | 0.0% | 1.70% | -24.7% | |
| XENE | XENON PHARMACEUTICALS INC | $7,570,000 | +4.0% | 406,535 | 0.0% | 1.58% | -8.3% | |
| ATRC | Sell | ATRICURE INC | $7,261,000 | -13.8% | 91,529 | -28.8% | 1.52% | -24.0% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $7,168,000 | +0.1% | 73,655 | 0.0% | 1.50% | -11.8% | |
| IDYA | IDEAYA BIOSCIENCES INC | $6,962,000 | -10.7% | 331,661 | 0.0% | 1.46% | -21.3% | |
| PRQR | Sell | PROQR THERAPEUTICS N V | $6,955,000 | -4.3% | 1,031,880 | -6.2% | 1.46% | -15.7% |
| IBB | Buy | ISHARES TR NASDAQ BIOTECHetf | $6,693,000 | +10.0% | 40,900 | +1.2% | 1.40% | -3.0% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $6,657,000 | -4.1% | 209,731 | +38.7% | 1.39% | -15.4% |
| CSII | CARDIOVASCULAR SYSTEMS INC | $6,385,000 | +11.3% | 149,700 | 0.0% | 1.34% | -2.0% | |
| FSTX | New | F-STAR THERAPEUTICS INC | $6,136,000 | – | 714,285 | +100.0% | 1.28% | – |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $6,041,000 | +4.7% | 53,000 | +10.4% | 1.26% | -7.7% |
| GLPG | Buy | GALAPAGOS NVspon adr | $5,351,000 | -7.7% | 77,675 | +3.3% | 1.12% | -18.6% |
| OTIC | Buy | OTONOMY INC | $5,306,000 | +434.3% | 2,379,392 | +510.7% | 1.11% | +370.3% |
| LMNX | Sell | LUMINEX CORP | $5,119,000 | +4.1% | 139,091 | -9.7% | 1.07% | -8.1% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $4,628,000 | -6.1% | 289,040 | +4.8% | 0.97% | -17.2% |
| CARA | Buy | CARA THERAPEUTICS INC | $4,495,000 | -20.8% | 315,000 | +20.5% | 0.94% | -30.2% |
| ARAY | ACCURAY INC | $4,257,000 | -8.7% | 941,800 | 0.0% | 0.89% | -19.5% | |
| STIM | NEURONETICS INC | $4,065,000 | +29.5% | 253,717 | 0.0% | 0.85% | +14.1% | |
| ACET | Sell | ADICET BIO INC | $3,872,000 | -23.1% | 376,281 | -2.3% | 0.81% | -32.2% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $3,733,000 | +275.6% | 47,852 | +355.3% | 0.78% | +230.9% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $3,711,000 | -0.7% | 4,000,000 | 0.0% | 0.78% | -12.5% | ||
| VERO | Sell | VENUS CONCEPT INC | $3,686,000 | +27.5% | 1,185,100 | -3.7% | 0.77% | +12.4% |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $3,571,000 | -15.2% | 1,126,613 | -9.8% | 0.75% | -25.2% |
| MRUS | MERUS N V | $3,326,000 | +0.9% | 157,841 | 0.0% | 0.70% | -11.0% | |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $3,287,000 | +103.3% | 119,700 | +107.8% | 0.69% | +78.9% |
| RDHL | REDHILL BIOPHARMA LTDsponsored ads | $3,137,000 | -6.0% | 455,933 | 0.0% | 0.66% | -17.2% | |
| FSII | FS DEVELOPMENT CORP II | $2,994,000 | +0.2% | 300,000 | 0.0% | 0.63% | -11.7% | |
| HOOK | Sell | HOOKIPA PHARMA INC | $2,951,000 | -36.1% | 322,124 | -6.2% | 0.62% | -43.7% |
| VKTX | VIKING THERAPEUTICS INC | $2,680,000 | -5.3% | 447,400 | 0.0% | 0.56% | -16.5% | |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $2,536,000 | +97.2% | 147,702 | +156.9% | 0.53% | +73.8% |
| NTUS | NATUS MEDICAL INC | $2,485,000 | +1.4% | 95,653 | 0.0% | 0.52% | -10.5% | |
| IPSC | New | CENTURY THERAPEUTICS INC | $2,347,000 | – | 80,000 | +100.0% | 0.49% | – |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $2,243,000 | +7.5% | 603,042 | 0.0% | 0.47% | -5.3% | |
| ASLN | ASLAN PHARMACEUTICALS LTDads | $2,236,000 | -1.5% | 677,500 | 0.0% | 0.47% | -13.2% | |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $2,225,000 | +45.1% | 510,386 | +51.1% | 0.46% | +27.7% |
| ETNB | Buy | 89BIO INC | $2,178,000 | -12.8% | 116,452 | +10.4% | 0.46% | -23.1% |
| BWAY | BRAINWAY LTDsponsored ads | $2,040,000 | +13.0% | 200,000 | 0.0% | 0.43% | -0.2% | |
| MEIP | Sell | MEI PHARMA INC | $1,827,000 | -17.6% | 641,000 | -0.8% | 0.38% | -27.4% |
| COGT | COGENT BIOSCIENCES INC | $1,813,000 | -7.6% | 223,554 | 0.0% | 0.38% | -18.7% | |
| IFRX | INFLARX NV | $1,782,000 | -23.8% | 600,000 | 0.0% | 0.37% | -32.8% | |
| ACRS | New | ACLARIS THERAPEUTICS INC | $1,756,000 | – | 100,000 | +100.0% | 0.37% | – |
| KURA | Buy | KURA ONCOLOGY INC | $1,742,000 | +19.0% | 83,529 | +61.3% | 0.36% | +4.9% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $1,742,000 | -13.4% | 128,263 | +3.2% | 0.36% | -23.7% |
| CGEN | Buy | COMPUGEN LTDord | $1,668,000 | +2.7% | 201,502 | +6.6% | 0.35% | -9.4% |
| ATHA | Buy | ATHIRA PHARMA INC | $1,648,000 | -2.1% | 160,983 | +75.9% | 0.34% | -13.8% |
| STRO | SUTRO BIOPHARMA INC | $1,580,000 | -18.3% | 85,000 | 0.0% | 0.33% | -28.1% | |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $1,546,000 | – | 100,000 | +100.0% | 0.32% | – |
| KDMN | KADMON HOLDINGS INC | $1,527,000 | -0.5% | 394,561 | 0.0% | 0.32% | -12.4% | |
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $1,497,000 | -3.8% | 1,500,000 | 0.0% | 0.31% | -15.2% | ||
| CFMS | CONFORMIS INC | $1,495,000 | +16.2% | 1,300,000 | 0.0% | 0.31% | +2.6% | |
| LVTX | New | LAVA THERAPEUTICS BV | $1,476,000 | – | 135,632 | +100.0% | 0.31% | – |
| NXTC | Buy | NEXTCURE INC | $1,473,000 | +126.3% | 183,491 | +182.3% | 0.31% | +100.0% |
| HARP | Sell | HARPOON THERAPEUTICS INC | $1,459,000 | -44.9% | 105,163 | -17.0% | 0.30% | -51.5% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $1,452,000 | -3.5% | 60,600 | +3.4% | 0.30% | -14.8% |
| INFI | INFINITY PHARMACEUTICALS INC | $1,373,000 | -7.4% | 459,260 | 0.0% | 0.29% | -18.5% | |
| KNTE | Buy | KINNATE BIOPHARMA INC | $1,267,000 | -23.2% | 54,415 | +2.8% | 0.26% | -32.2% |
| ISEE | Buy | IVERIC BIO INC | $1,135,000 | +104.1% | 179,951 | +100.1% | 0.24% | +79.5% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $1,059,000 | +12.4% | 244,000 | -11.4% | 0.22% | -0.9% |
| ALPN | ALPINE IMMUNE SCIENCES INC | $1,020,000 | -15.1% | 113,302 | 0.0% | 0.21% | -25.3% | |
| INGN | INOGEN INC | $978,000 | +24.1% | 15,000 | 0.0% | 0.20% | +9.6% | |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $939,000 | -68.6% | 7,137 | -69.3% | 0.20% | -72.4% |
| SRGA | New | SURGALIGN HOLDINGS INC | $806,000 | – | 579,710 | +100.0% | 0.17% | – |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $803,000 | -58.4% | 12,703 | -71.7% | 0.17% | -63.2% |
| LRMR | Sell | LARIMAR THERAPEUTICS INC | $756,000 | -36.5% | 76,987 | -5.5% | 0.16% | -44.0% |
| VBLT | New | VASCULAR BIOGENICS LTD | $734,000 | – | 306,980 | +100.0% | 0.15% | – |
| MASI | MASIMO CORPORATION | $727,000 | +5.5% | 3,000 | 0.0% | 0.15% | -6.7% | |
| GNFT | GENFIT S Aads | $716,000 | -17.8% | 188,549 | 0.0% | 0.15% | -27.5% | |
| NGM | Buy | NGM BIOPHARMACEUTICALS INC | $601,000 | +106.5% | 30,502 | +205.0% | 0.13% | +82.6% |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $545,000 | -16.8% | 5,600 | 0.0% | 0.11% | -26.5% | |
| RDUS | RADIUS HEALTH INC | $264,000 | -12.6% | 14,500 | 0.0% | 0.06% | -23.6% | |
| SCPH | SCPHARMACEUTICALS INC | $238,000 | -8.1% | 38,891 | 0.0% | 0.05% | -18.0% | |
| CNTB | CONNECT BIOPHARMA HLDGS LTDads | $156,000 | +5.4% | 8,000 | 0.0% | 0.03% | -5.7% | |
| VRNA | Exit | VERONA PHARMA PLCsponsored ads | $0 | – | -18,337 | -100.0% | -0.04% | – |
| LCTX | Exit | LINEAGE CELL THERAPEUTICS INC | $0 | – | -75,400 | -100.0% | -0.04% | – |
| XFOR | Exit | X4 PHARMACEUTICALS INC | $0 | – | -69,912 | -100.0% | -0.14% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -197,500 | -100.0% | -0.15% | – |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -89,874 | -100.0% | -0.17% | – |
| JNJ | Exit | JOHNSON AND JOHNSON | $0 | – | -9,400 | -100.0% | -0.37% | – |
| LQDA | Exit | LIQUIDIA TECHNOLOGIES INC | $0 | – | -575,000 | -100.0% | -0.37% | – |
| GMTX | Exit | GEMINI THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.48% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -83,000 | -100.0% | -0.51% | – |
| AGTC | Exit | APPLIED GENETIC TECHNOL CORP | $0 | – | -430,111 | -100.0% | -0.52% | – |
| ALEC | Exit | ALECTOR INC | $0 | – | -127,500 | -100.0% | -0.61% | – |
| PLX | Exit | PROTALIX BIOTHERAPEUTICS INC | $0 | – | -1,204,825 | -100.0% | -1.28% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.